|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Is scleral fixation a safe procedure for intraoeular lens implantation 显示文摘 | LANZETTA P BANDELLO FM VIRIGILI G | 1999 | Doe Ophthalmol1999，97，34： | 1 |
| 2 | Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy 显示文摘 | BANDELLO F POGNUZ D R PIRRACCHIO A | 2004 | Graefes Arch Clin Exp Ophthalmol2004，242，12： | 1 |
| 3 | Safety and efficacy ofranibizumab in diabetic macular edema ( RESOLVE Study) : a 12-month ,randomized, controlled, double-masked, multicenter phaseII study 显示文摘 | Massin P Bandello F Garweg JG | 2010 | Diabetes Care2010，33，11： | 1 |
| 4 | Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESLOVE): a 12- month randomized, controlled, double-masked, multicenter phase II study 显示文摘 | Massin P Bandello F Garweg JG | 2010 | Diabetes Care2010，33，11： | 1 |
| 5 | Randomized,Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion显示文摘 | Haller JA Bandello F Belfort R | 2010 | Ophthalmology2010，117，6： | 1 |
| 6 | Safety of ranibizumab in routine clinical practice: 1-year retrospective pooled analysis of four European neovascular AMD registries within the LUMINOUS programme显示文摘 | Holz FG Bandello F Gillies M | 2013 | Br J Ophthalmol2013，97，9： | 1 |
| 7 | The RESTORE study: Ranibizumabmonotherapy or combined with laser versus monotherapy for diabetic macular edema 显示文摘 | Mitchell P Bandello F Schmidt-Erfurth U | 2011 | Ophthalmology2011，118，4： | 1 |
| 8 | Diabetic papillopathy as a risk factor for progression of diabetic retinopathy 显示文摘 | Bandello F Menchini F | 2004 | Retina2004，24，1： | 1 |
| 9 | Diabetic retinopathy:a clinical update显示文摘 | Porta M Bandello F | 2002 | Diabetologia2002，45，： | 1 |
| 10 | Triamcinolone as adjunctive treatment to laser panretinal photocoagulation for proliferative diabetic retinopathy 显示文摘 | Bandello F Polito A Pognuz DR | 2006 | Arch Ophthalmol2006，124，： | 1 |
| 11 | The RESTORE Study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema显示文摘 | Mitchell P Bandello F Schmidt-Erfurth U | 2011 | Ophthalmology2011，118，4： | 1 |
| 12 | Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study re- sults 显示文摘 | Hailer JA Bandello F Belfort R Jr et at | 2011 | Ophthalmology2011，118，： | 1 |
| 13 | Increased risk of postsurgical macular edema in high stage idiopathic epiretinal membranes显示文摘Purpose:To assess the rate of occurrence and the risk factors of postsurgical macular edema(PSME)in eyes with idiopathic epiretinal membrane(iERM)or full-thickness macular hole(FTMH).Methods:Retrospective longitudinal analysis of all subjects scheduled for vitrectomy with or without combined cataract surgery over a 6-month period.Electronic medical charts and imaging data were analyzed preoperatively and at 1,3 and 6 months after surgery.Results:From 101 patients diagnosed with iERM or FTMH,71 patients were eligible for the study.Forty-nine eyes with iERM(69.0%)and 22 eyes with FTMH(31.0%)underwent vitrectomy either isolated(31.0%)or combined with cataract extraction(69.0%).The overall rate of PSME was 26.7%,without differences between the two groups(P=0.9479).Combined cataract extraction did not affect the overall occurrence of PSME rate in both groups(P=0.9255 in FTMH and P=0.8658 in iERM).If grouped by stage,eyes with stage 4 iERM though disclosed an increased rate of PSME(57.1%)compared to lower(1 to 3)stages(14.3%,P=0.0021),particularly when combined with cataract surgery(71.4%vs.15.4%in stages≤3,P=0.0021).The PSME odds ratio for a stage 4 iERM is 8(95%CI:1.933-33.1;P=0.0041)compared to stages 3 and below.Conclusions:PSME remains a clinically relevant and frequent event after surgery for iERM and FTMH.Patients with stage 4 iERM have an 8-fold higher likelihood of developing PSME in a 6-month postsurgical period compared to iERM in 1-3 stages,especially when combined with cataract extraction. | Lorenzo Iuliano Gloria Cisa di Gresy Giovanni Fogliato Eleonora Corbelli Francesco Bandello Marco Codenotti | 2021 | Eye and Vision2021，8，1： | 1 |
| 14 | New approaches for the treatment of diabetic macular oedema:recommendations by an expert panel显示文摘 | Bandello F Cunha Vaz J Chong N V | 2012 | Eye2012，26，4： | 1 |
| 15 | Onset and duration of visual acuity improvement after dexamethasone in- travitreal implant in eyes with macular edema due to retinal vein occlusion 显示文摘 | Kuppermann BD Hailer JA Bandello F | 2014 | Retina2014，34，： | 1 |
| 16 | Safety of ranibizumab in routine clinical practice : 1 - year retrospective pooled analysis offour European neovascular AMD registries within the LUMINOUS programme 显示文摘 | Holz FG Bandello F Gillies M | 2013 | Br J Ophthalmol2013，97，9： | 1 |
| 17 | Retinal arteriolar obstruction with progestogen treatment of threatened abortion显示文摘 | Lanzetta P Crovato S Pirracchio A Bandello F | 2002 | ActaOphthalmolScand2002，80，： | 1 |
| 18 | Central serous retinopathy( atypical forms) 显示文摘 | Brancato R Bandello F | 1991 | Bull Soc Bedge 0phthalmol1991，240，： | 1 |
| 19 | The RE- STORE study: ranibizumab monotherapy or combined with la- ser versus laser monotherapy for diabetic macular edema 显示文摘 | Mitchell P Bandello F Schmidt-Erfurth U | 2011 | Ophthalmology2011，118，： | 1 |
| 20 | Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study) : a 12-month, randomized, controlled, double-masked, multi- center phase II study 显示文摘 | Massin P Bandello F Garweg JG | 2010 | Diabetes Care2010，33，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员